Coronary Artery Disease. We see you.
For personal use only
ASX ANNOUNCEMENT
MARKET RELEASE
27 July 2022
Updated Appendix 4C for Q4 FY22
Artrya Limited (ASX: AYA), ("Artrya" or the "Company"), a medical technology company focused on commercialising its patented artificial intelligence platform, advises that there was an error on page 1 of the Appendix 4C Cash Flow Report for the quarter ended 30 June 2022 (Appendix 4C). On page 1 of the Appendix 4C, some of the year to date individual items for cash flows from operating activities were not correct and have now been corrected, however the net cash from / (used in) operating activities total for the current quarter and year to date (12 Months) have not changed. There are no other changes to the Appendix 4C. An updated Appendix 4C is now attached.
This announcement was approved by the Company's Managing Director, John Barrington, on behalf of the Artrya
Board.
For further information please contact | |
Investor Enquiries: | Media Enquiries: |
John Barrington | Brett McCarthy |
Artrya Limited | Artrya Limited |
+61 419 850 502 | +61 401 704 451 |
investors@artrya.com | brett.mccarthy@artrya.com |
About Artrya
Based in Perth, Australia, Artrya was founded in 2018 and commenced operations in early 2019. Artrya Ltd is listed on the Australian Securities Exchange (ASX: AYA).
Artrya is an applied artificial intelligence healthcare company that works alongside clinicians to improve the diagnosis of coronary heart disease and develop a holistic overview of a patient at risk. The company has developed deep learning algorithms that will allow for the prediction and prevention of acute coronary events.
For more information, see www.artrya.com
Artrya Limited
ACN 624 005 741
1257 Hay Street West Perth WA 6005 PO Box 567 West Perth WA 6872 www.artrya.com
T: +61 8 6478 7816
For personal use only
Rule 4.7B
Appendix 4C
Quarterly cash flow report for entities subject to Listing Rule 4.7B
Name of entity
Artrya Limited | |
ABN | Quarter ended ("current quarter") |
53 624 005 741 | 30 June 2022 |
Consolidated statement of cash flows | Current quarter | Year to date | ||
$A'000 | (12 months) | |||
$A'000 | ||||
1. | Cash flows from operating activities | |||
1.1 | Receipts from customers | - | - | |
1.2 | Payments for | |||
(a) | research and development | (1,110) | (2,589) | |
(b) product manufacturing and operating | (562) | (2,746) | ||
costs | ||||
(c) | advertising and marketing | (397) | (2,099) | |
(d) | leased assets | (78) | (85) | |
(e) | staff costs | (1,696) | (5,023) | |
(f) administration and corporate costs | (371) | (1,507) | ||
1.3 | Dividends received (see note 3) | - | ||
1.4 | Interest received | 20 | 30 | |
1.5 | Interest and other costs of finance paid | (13) | (13) | |
1.6 | Income taxes paid | - | ||
1.7 | Government grants and tax incentives | 15 | 992 | |
1.8 | Other (provide details if material) | - | - | |
1.9 | Net cash from / (used in) operating | (4,192) | (13,040) | |
activities | ||||
2. | Cash flows from investing activities | |||
2.1 | Payments to acquire or for: | |||
(a) | entities | - | - | |
(b) | businesses | - | - | |
(c) property, plant and equipment | (1,007) | (1,906) | ||
(d) | investments ** | 9,000 | (20,000) | |
(e) | intellectual property | (75) | (243) | |
(f) | other non-current assets | - | - |
ASX Listing Rules Appendix 4C (17/07/20) | Page 1 |
+ See chapter 19 of the ASX Listing Rules for defined terms. |
For personal use only
Appendix 4C
Quarterly cash flow report for entities subject to Listing Rule 4.7B
Consolidated statement of cash flows | Current quarter | Year to date | ||
$A'000 | (12 months) | |||
$A'000 | ||||
2.2 | Proceeds from disposal of: | |||
(a) | entities | - | - | |
(b) | businesses | - | - | |
(c) | property, plant and equipment | 4 | 4 | |
(d) | investments | - | - | |
(e) | intellectual property | - | - | |
(f) | other non-current assets | - | - | |
2.3 | Cash flows from loans to other entities | - | - | |
2.4 | Dividends received (see note 3) | - | - | |
2.5 | Other (provide details if material) | - | - | |
2.6 | Net cash from / (used in) investing | 7,922 | (22,145) | |
activities | ||||
3. Cash flows from financing activities
3.1 Proceeds from issues of equity securities
(excluding convertible debt securities) | - | 40,000 | |
3.2 | Proceeds from issue of convertible debt | - | - |
securities | |||
3.3 | Proceeds from exercise of options | - | 10 |
3.4 | Transaction costs related to issues of | - | (3,023) |
equity securities or convertible debt | |||
securities | |||
3.5 | Proceeds from borrowings | - | - |
3.6 | Repayment of borrowings | - | - |
3.7 | Transaction costs related to loans and | - | - |
borrowings | |||
3.8 | Dividends paid | - | - |
3.9 | Other (rental incentives) | 898 | 898 |
3.10 | Net cash from / (used in) financing | 898 | 37,885 |
activities | |||
4. Net increase / (decrease) in cash and cash equivalents for the period
4.1 Cash and cash equivalents at beginning of
period | 10,925 | 12,853 | |
4.2 | Net cash from / (used in) operating | (4,192) | (13,106) |
activities (item 1.9 above) | |||
4.3 | Net cash from / (used in) investing activities | 7,922 | (22,145) |
(item 2.6 above) |
ASX Listing Rules Appendix 4C (17/07/20) | Page 2 |
+ See chapter 19 of the ASX Listing Rules for defined terms. |
Appendix 4C Quarterly cash flow report for entities subject to Listing Rule 4.7B
only
Consolidated statement of cash flows
- Net cash from / (used in) financing activities (item 3.10 above)
- Effect of movement in exchange rates on cash held
- Cash and cash equivalents at end of period **
Current quarter | Year to date |
$A'000 | (12 months) |
$A'000 | |
898 | 37,885 |
5 | 5 |
15,558 | 15,558 |
For personal use
5. | Reconciliation of cash and cash | Current quarter | Previous quarter |
equivalents | $A'000 | $A'000 | |
at the end of the quarter (as shown in the | |||
consolidated statement of cash flows) to the | |||
related items in the accounts | |||
5.1 | Bank balances ** | 15,558 | 10,925 |
5.2 | Call deposits | - | - |
5.3 | Bank overdrafts | - | - |
5.4 | Other (provide details) | - | - |
5.5 | Cash and cash equivalents at end of | 15,558 | 10,925 |
quarter (should equal item 4.6 above) |
6. | Payments to related parties of the entity and their | Current quarter |
associates | $A'000 | |
6.1 | Aggregate amount of payments to related parties and their | 279 |
associates included in item 1 | ||
6.2 | Aggregate amount of payments to related parties and their | - |
associates included in item 2 |
Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must include a description of, and an explanation for, such payments.
ASX Listing Rules Appendix 4C (17/07/20) | Page 3 |
+ See chapter 19 of the ASX Listing Rules for defined terms. |
use only
Appendix 4C
Quarterly cash flow report for entities subject to Listing Rule 4.7B
7. | Financing facilities | Total facility | Amount drawn at |
Note: the term "facility' includes all forms of financing | amount at quarter | quarter end | |
arrangements available to the entity. | end | $A'000 | |
Add notes as necessary for an understanding of the | |||
$A'000 | |||
sources of finance available to the entity. | |||
7.1 | Loan facilities | - | - |
7.2 | Credit standby arrangements | - | - |
7.3 | Other (see table 7.6 below) | 285 | 84 |
7.4 | Total financing facilities | 285 | 84 |
7.5 | Unused financing facilities available at quarter end | 201 |
7.6 Include in the box below a description of each facility above, including the lender, interest rate, maturity date and whether it is secured or unsecured. If any additional financing facilities have been entered into or are proposed to be entered into after quarter end, include a note providing details of those facilities as well.
Other financing facilities - corporate credit cards
Facility | Facility limit | Amount drawn | Interest rate | Secured |
$A'000 | $A'000 | |||
American Express | 160 | 2 | 6.99% p.a. | No |
- credit cards | ||||
Bankwest - credit | 125 | 3 | 17.99% p.a. | Guarantee deposit |
cards | ||||
285 | 5 | |||
personal
8. Estimated cash available for future operating activities
8.1 Net cash from / (used in) operating activities (item 1.9)
8.2 Cash and cash equivalents at quarter end (item 4.6)
8.3 Unused finance facilities available at quarter end (item 7.5)
8.4 Total available funding (item 8.2 + item 8.3) **
8.5 Estimated quarters of funding available (item 8.4 divided by item 8.1) **
$A'000
(4,192)
15,558
201
15,759
3.76
For
Note: if the entity has reported positive net operating cash flows in item 1.9, answer item 8.5 as "N/A". Otherwise, a figure for the estimated quarters of funding available must be included in item 8.5.
8.6 If item 8.5 is less than 2 quarters, please provide answers to the following questions:
8.6.1 Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not?
Answer:
8.6.2 Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?
Answer:
ASX Listing Rules Appendix 4C (17/07/20) | Page 4 |
+ See chapter 19 of the ASX Listing Rules for defined terms. |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Artrya Ltd. published this content on 27 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 July 2022 08:31:09 UTC.